Published in Liver Transpl on November 01, 2008
Extensive multifocal branch duct IPMN of the pancreas after liver transplantation: is surgery justified? Eur J Med Res (2015) 1.40
Long-term probability of and mortality from de novo malignancy after liver transplantation. Gastroenterology (2009) 1.18
Risk of lymphoma subtypes after solid organ transplantation in the United States. Br J Cancer (2013) 1.17
Increased risk for lymphoid and myeloid neoplasms in elderly solid-organ transplant recipients. Cancer Epidemiol Biomarkers Prev (2010) 1.03
Systematic review of melanoma incidence and prognosis in solid organ transplant recipients. Transplant Res (2014) 0.96
Current understanding of lifestyle and environmental factors and risk of non-hodgkin lymphoma: an epidemiological update. J Cancer Epidemiol (2012) 0.95
Liver transplantation: immunosuppression and oncology. Curr Opin Organ Transplant (2014) 0.94
De novo malignancy post-liver transplantation: a single center, population controlled study. Clin Transplant (2013) 0.91
Evolution and management of de novo neoplasm post-liver transplantation: a 20-year experience from a single European centre. Hepatol Int (2010) 0.86
Organ donation and transplantation in Canada: insights from the Canadian Organ Replacement Register. Can J Kidney Health Dis (2014) 0.79
Risk of Colorectal Cancer After Solid Organ Transplantation in the United States. Am J Transplant (2016) 0.79
Incidence, risk factors and outcomes of de novo malignancies post liver transplantation. World J Hepatol (2016) 0.78
Risk of cancer in liver transplant recipients: a look into the mirror. Liver Transpl (2008) 0.77
Increased incidence of head and neck cancer in liver transplant recipients: a meta-analysis. BMC Cancer (2014) 0.77
Incidence, risk factors and outcome of de novo tumors in liver transplant recipients focusing on alcoholic cirrhosis. World J Hepatol (2015) 0.76
Malignancies in a renal transplant population: The St. Michael's Hospital experience. Urol Ann (2016) 0.75
Solid, non-skin, post-liver transplant tumors: Key role of lifestyle and immunosuppression management. World J Gastroenterol (2016) 0.75
Posttransplant lymphoproliferative disorders following liver transplantation: Where are we now? World J Gastroenterol (2015) 0.75
Cancer Incidence among Heart, Kidney, and Liver Transplant Recipients in Taiwan. PLoS One (2016) 0.75
Comparison of hematological alterations and markers of B-cell activation in workers exposed to benzene, formaldehyde and trichloroethylene. Carcinogenesis (2016) 0.75
Risk Factors and Outcomes of De novo Cancers (Excluding Nonmelanoma Skin Cancer) after Liver Transplantation for Primary Sclerosing Cholangitis. Transplantation (2017) 0.75
Global estimates of ambient fine particulate matter concentrations from satellite-based aerosol optical depth: development and application. Environ Health Perspect (2010) 6.41
The survival benefit of liver transplantation. Am J Transplant (2005) 5.08
A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index. Transplantation (2009) 4.45
US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis (2015) 3.94
Risk of nonaccidental and cardiovascular mortality in relation to long-term exposure to low concentrations of fine particulate matter: a Canadian national-level cohort study. Environ Health Perspect (2012) 3.39
Dialysis outcomes and analysis of practice patterns suggests the dialysis schedule affects day-of-week mortality. Kidney Int (2012) 3.02
Sarcopenia and mortality after liver transplantation. J Am Coll Surg (2010) 2.75
A systematic review of the relation between long-term exposure to ambient air pollution and chronic diseases. Rev Environ Health (2009) 2.43
Health-state utilities and quality of life in hepatitis C patients. Am J Gastroenterol (2003) 2.42
Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza. CMAJ (2010) 2.36
Rates of solid-organ wait-listing, transplantation, and survival among residents of rural and urban areas. JAMA (2008) 2.24
A case-control study of long-term exposure to ambient volatile organic compounds and lung cancer in Toronto, Ontario, Canada. Am J Epidemiol (2013) 2.05
Semiparametric analysis of correlated recurrent and terminal events. Biometrics (2007) 2.00
Racial and ethnic disparities in access to liver transplantation. Liver Transpl (2010) 1.94
Effect of alcoholic liver disease and hepatitis C infection on waiting list and posttransplant mortality and transplant survival benefit. Hepatology (2009) 1.84
Re-weighting the model for end-stage liver disease score components. Gastroenterology (2008) 1.83
Kidneys from donors after cardiac death provide survival benefit. J Am Soc Nephrol (2010) 1.76
Serum sodium and survival benefit of liver transplantation. Liver Transpl (2015) 1.75
Evaluating the survival benefit of kidney retransplantation. Transplantation (2006) 1.75
Association of obesity and cancer risk in Canada. Am J Epidemiol (2004) 1.71
Effect of body mass index on the survival benefit of liver transplantation. Liver Transpl (2007) 1.69
Analytic morphomics, core muscle size, and surgical outcomes. Ann Surg (2012) 1.65
The influence of ambient coarse particulate matter on asthma hospitalization in children: case-crossover and time-series analyses. Environ Health Perspect (2002) 1.57
Who should get a liver graft? J Hepatol (2009) 1.56
New approaches to immigrant health assessment. Can J Public Health (2004) 1.55
Intentional versus unintentional contact as a mechanism of injury in youth ice hockey. Br J Sports Med (2010) 1.51
Mortality among Canadian women with cosmetic breast implants. Am J Epidemiol (2006) 1.51
Disparities in mortality patterns among Canadian immigrants and refugees, 1980-1998: results of a national cohort study. J Immigr Health (2005) 1.51
Evidence-based development of liver allocation: a review. Transpl Int (2011) 1.50
Hepatitis C is a risk factor for death after liver retransplantation. Liver Transpl (2005) 1.48
Frailty, core muscle size, and mortality in patients undergoing open abdominal aortic aneurysm repair. J Vasc Surg (2011) 1.47
Survival on dialysis post-kidney transplant failure: results from the Scientific Registry of Transplant Recipients. Am J Kidney Dis (2007) 1.47
A Reassessment of the Survival Advantage of Simultaneous Kidney-Pancreas Versus Kidney-Alone Transplantation. Transplantation (2015) 1.44
Portal vein thrombosis and liver transplant survival benefit. Liver Transpl (2010) 1.42
Avoidable mortality in the United States and Canada, 1980-1996. Am J Public Health (2002) 1.41
US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis (2016) 1.37
Marginal means/rates models for multiple type recurrent event data. Lifetime Data Anal (2004) 1.37
Baseline comorbidity in kidney transplant recipients: a comparison of comorbidity indices. Am J Kidney Dis (2005) 1.32
Histology-related variation in the treatment and survival of patients with lung carcinoma in Canada. Lung Cancer (2003) 1.29
Long-term fine particulate matter exposure and mortality from diabetes in Canada. Diabetes Care (2013) 1.29
Risk of asthmatic episodes in children exposed to sulfur dioxide stack emissions from a refinery point source in Montreal, Canada. Environ Health Perspect (2008) 1.27
Risk of incident diabetes in relation to long-term exposure to fine particulate matter in Ontario, Canada. Environ Health Perspect (2013) 1.26
Gaseous air pollutants and asthma hospitalization of children with low household income in Vancouver, British Columbia, Canada. Am J Epidemiol (2004) 1.25
Estimating differences in restricted mean lifetime using observational data subject to dependent censoring. Biometrics (2010) 1.25
End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates. Hepatology (2011) 1.19
The inflammatory bowel diseases and ambient air pollution: a novel association. Am J Gastroenterol (2010) 1.19
A case-control study of diet and the risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev (2004) 1.19
Determinants of health-related quality of life of opiate users at entry to low-threshold methadone programs. Eur Addict Res (2006) 1.15
Residential proximity to industrial plants and non-Hodgkin lymphoma. Epidemiology (2003) 1.13
Reduction in injection-related HIV risk after 6 months in a low-threshold methadone treatment program. AIDS Educ Prev (2007) 1.13
Increasing incidence of non-Hodgkin's lymphoma in Canada, 1970-1996: age-period-cohort analysis. Hematol Oncol (2003) 1.13
Cancer incidence among Canadian immigrants, 1980-1998: results from a national cohort study. J Immigr Minor Health (2011) 1.11
Ambient PM2.5, O3, and NO2 Exposures and Associations with Mortality over 16 Years of Follow-Up in the Canadian Census Health and Environment Cohort (CanCHEC). Environ Health Perspect (2015) 1.11
Long-term exposure to traffic-related air pollution and cardiovascular mortality. Epidemiology (2013) 1.11
Estimating cumulative treatment effects in the presence of nonproportional hazards. Biometrics (2007) 1.11
Effect of ambient air pollution on the incidence of appendicitis. CMAJ (2009) 1.10
Double-robust semiparametric estimator for differences in restricted mean lifetimes in observational studies. Biometrics (2012) 1.10
Air pollution and emergency department visits for asthma in Windsor, Canada. Can J Public Health (2012) 1.10
Diet and vitamin or mineral supplements and risk of renal cell carcinoma in Canada. Cancer Causes Control (2003) 1.09
The effect of salvage therapy on survival in a longitudinal study with treatment by indication. Stat Med (2010) 1.06
Effect of pretransplant serum creatinine on the survival benefit of liver transplantation. Liver Transpl (2009) 1.06
Evaluating bias correction in weighted proportional hazards regression. Lifetime Data Anal (2008) 1.06
PM2.5, oxidant defence and cardiorespiratory health: a review. Environ Health (2013) 1.05
Cognitive dysfunction after total knee arthroplasty: effects of intraoperative cerebral embolization and postoperative complications. J Arthroplasty (2005) 1.05
Self-perceived health among Canadian opiate users: a comparison to the general population and to other chronic disease populations. Can J Public Health (2004) 1.05
The burden of adult obesity in Canada. Chronic Dis Can (2007) 1.05
Contrasting treatment-specific survival using double-robust estimators. Stat Med (2012) 1.04
Cluster of liver cancer and immigration: a geographic analysis of incidence data for Ontario 1998-2002. Int J Health Geogr (2008) 1.04
Patient-specific prediction of ESRD after liver transplantation. J Am Soc Nephrol (2013) 1.04
Access to renal transplantation for minority patients with ESRD in Canada. Am J Kidney Dis (2004) 1.03
Physical activity and the risk of ovarian cancer: a case-control study in Canada. Int J Cancer (2005) 1.01
Risk factors for lung cancer among Canadian women who have never smoked. Cancer Detect Prev (2002) 1.00
A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation. Liver Transpl (2009) 1.00
Short-term pretransplant renal replacement therapy and renal nonrecovery after liver transplantation alone. Clin J Am Soc Nephrol (2013) 0.99
Survival of patients diagnosed with either colorectal mucinous or non-mucinous adenocarcinoma: a population-based study in Canada. Int J Oncol (2009) 0.99
Cause-deleted health-adjusted life expectancy of Canadians with selected chronic conditions. Chronic Dis Can (2003) 0.98
Long-term exposure to fine particulate matter: association with nonaccidental and cardiovascular mortality in the agricultural health study cohort. Environ Health Perspect (2014) 0.97
Health state utilities and quality of life in patients with hepatitis B. Can J Gastroenterol (2012) 0.97
Cancer incidence patterns among Chinese immigrant populations in Alberta. J Immigr Health (2004) 0.97
Physical activity, obesity, energy intake, and the risk of non-Hodgkin's lymphoma: a population-based case-control study. Am J Epidemiol (2005) 0.96
Adolescent injury deaths and hospitalization in Canada: magnitude and temporal trends (1979-2003). J Adolesc Health (2007) 0.96
Total fluid and specific beverage intake and risk of renal cell carcinoma in Canada. Cancer Epidemiol (2009) 0.96
An epidemiologic study of hepatocellular carcinoma in Canada. Can J Public Health (2002) 0.95
Survival benefit of kidney and liver transplantation for obese patients on the waiting list. Clin Transpl (2003) 0.95
Avoidable mortality across Canada from 1975 to 1999. BMC Public Health (2006) 0.94
Weight gain in children with hypertonia of cerebral origin receiving intrathecal baclofen therapy. Arch Phys Med Rehabil (2006) 0.93
Living-donor right hepatectomy with or without inclusion of middle hepatic vein: comparison of morbidity and outcome in 56 patients. Am J Transplant (2004) 0.93
The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age. Liver Transpl (2008) 0.92
The role of donor-recipient relationship in long-term outcomes of living donor renal transplantation. Transplantation (2008) 0.92
Impact of immunosuppressive regimen on survival of kidney transplant recipients with hepatitis C. Transplantation (2008) 0.92
De novo sequencing of heparan sulfate oligosaccharides by electron-activated dissociation. Anal Chem (2013) 0.92
Association of cigarette smoking with the risk of ovarian cancer. Int J Cancer (2004) 0.91
Ecological analysis of long-term exposure to ambient air pollution and the incidence of stroke in Edmonton, Alberta, Canada. Stroke (2010) 0.91
Analytical approaches for transplant research. Am J Transplant (2004) 0.91
An estimating function approach to the analysis of recurrent and terminal events. Biometrics (2013) 0.91
Cancer incidence in a cohort of Ontario and Quebec women having bilateral breast augmentation. Int J Cancer (2006) 0.90
Long-term follow-up of kidney transplant recipients: comparison of hospitalization rates to the general population. Transplant Res (2013) 0.90